← back to search

Silke Eisinger

Karolinska Institutet · SE
Area of research
Organic Chemistry · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Breast Cancer Therapies, Click Chemistry and Applications, Cancer-related Molecular Pathways, and Cancer therapeutics and mechanisms.
h-index
3
citations
219
works
29
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer
iScience 2022cited by 32position: middledoi
Targeting Myeloid Suppressive Cells Revives Cytotoxic Anti-Tumor Responses in Pancreatic Cancer
SSRN Electronic Journal 2022cited by 1position: middledoi
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
Proceedings of the National Academy of Sciences 2020cited by 171position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dhifaf Sarhan · Karolinska Institutet3 papers (2020–2022)Mikael C. I. Karlsson · Uppsala University3 papers (2020–2022)— · 2 papers (2022–2022)Shuijie Li · Harbin Medical University2 papers (2022–2022)— · 2 papers (2022–2022)Björn Önfelt · Karolinska Institutet2 papers (2022–2022)— · 2 papers (2022–2022)Matthias Löhr · Sanford Health2 papers (2022–2022)Itziar Ibarlucea Benitez · Rockefeller University2 papers (2022–2022)Susanne Schlisio · Karolinska University Hospital2 papers (2022–2022)Rainer Heuchel · Karolinska Institutet2 papers (2022–2022)Valentina Carannante · Science for Life Laboratory2 papers (2022–2022)Fei He · Southern University of Science and Technology2 papers (2022–2022)Jeffrey V. Ravetch · Rockefeller University2 papers (2020–2022)Catarina Pelicano · University of Cambridge2 papers (2022–2022)David P. Lane · Science for Life Laboratory1 papers (2020–2020)Shigeaki Kanatani · Karolinska Institutet1 papers (2020–2020)Rolf Kiessling · Karolinska Institutet1 papers (2020–2020)Itziar Ibarlucea-Benitez · University of California, Berkeley1 papers (2020–2020)Saikiran K. Sedimbi · Karolinska Institutet1 papers (2020–2020)